Moderna COVID-19 vaccine

GPTKB entity

Statements (62)
Predicate Object
gptkbp:instanceOf vaccine
gptkbp:age adults 18 years and older
children 6 months and older (in some countries)
gptkbp:approvedBy gptkb:World_Health_Organization
gptkb:European_Medicines_Agency
gptkb:U.S._Food_and_Drug_Administration
gptkbp:ATCCode gptkb:J07BX03
gptkbp:boosterInterval at least 5 months after primary series
gptkbp:boosters yes
gptkbp:brand gptkb:Spikevax
gptkbp:CDC_Vaccine_Code 91301
gptkbp:clinicalTrialPhase July 2020 - November 2020
gptkbp:contains lipid nanoparticles
mRNA encoding SARS-CoV-2 spike protein
gptkbp:countryOfOperation gptkb:Australia
gptkb:Canada
gptkb:European_Union
gptkb:India
gptkb:Japan
gptkb:United_Kingdom
gptkb:United_States
many other countries
gptkbp:countryOfOrigin gptkb:United_States
gptkbp:developedBy gptkb:Moderna
gptkb:National_Institute_of_Allergy_and_Infectious_Diseases
gptkbp:dosageSchedule two doses, 28 days apart
gptkbp:efficacyAgainstOriginalStrain ~94%
gptkbp:emergencyServices December 2020
gptkbp:excludes adjuvant
live virus
preservative
egg protein
gptkbp:firstDoseAdministeredDate December 2020
gptkbp:fullApprovalDate January 2022
https://www.w3.org/2000/01/rdf-schema#label Moderna COVID-19 vaccine
gptkbp:lactationCategory consult healthcare provider
gptkbp:legalStatus prescription only
gptkbp:patent gptkb:Moderna
gptkbp:pregnancyCategory consult healthcare provider
gptkbp:routeOfAdministration intramuscular injection
gptkbp:sideEffect fever
nausea
fatigue
headache
muscle pain
pericarditis
chills
myocarditis
pain at injection site
gptkbp:storage -20°C
gptkbp:storageDurationAt-20C up to 6 months
gptkbp:storageDurationAt2to8C up to 30 days
gptkbp:target gptkb:COVID-19
gptkbp:technology messenger RNA
gptkbp:UNII QDW8MXH2FS
gptkbp:updatedBivalentFormulation available since 2022
gptkbp:updatedMonovalentFormulation available since 2023
gptkbp:variantAdaptedFormulations yes
gptkbp:WHO_EUL_listing_date April 2021
gptkbp:bfsParent gptkb:COVID-19
gptkb:COVID-19_pandemic
gptkbp:bfsLayer 4